Combination [mnob]    
Age [orga]    
Hepatitis B surface antigen level [lbpr]    
post treatment [tmco]    
Id [fish]    
Analog [chvs]    
Induce [ftcn]    
Hepatitis B e antigen [imft]    
Background [cnce]    
studies [mnob]    
Indicated [fndg]    
Induce [ftcn]    
Hepatitis B e antigen [imft]    
Not [ftcn]    
Asian [popg]    
Population [qnco]    
investigate [ftcn]    
use [ftcn]    
Predictor [idcn]    
post treatment [tmco]    
Hepatitis B Virus [virs]    
Relapse [phpr]    
patient [podg]    
Id [fish]    
Analog [chvs]    
Induce [ftcn]    
Hepatitis B e antigen [imft]    
Loss [qnco]    
% total [qnco]    
Non-cirrhotic [qlco]    
patient [podg]    
Induce [ftcn]    
Hepatitis B e antigen [imft]    
Loss [qnco]    
68 [inpr]    
Analyzed [resa]    
patient [podg]    
less [inpr]    
month [tmco]    
post treatment [tmco]    
Follow-up [fndg]    
Consolidation Therapy [topp]    
Duration [tmco]    
Cumulative [qlco]    
Rate [acty]    
post treatment [tmco]    
Hepatitis B Virus [virs]    
Relapse [phpr]    
>5 [qnco]    
year [tmco]    
Multivariate Analysis [qnco]    
reveal [qlco]    
Age [orga]    
baseline [bodm]    
Hepatitis B surface antigen level [lbpr]    
Predictability [idcn]    
post treatment [tmco]    
Hepatitis B Virus [virs]    
Relapse [phpr]    
post treatment [tmco]    
Hepatitis B Virus [virs]    
Relapse [phpr]    
Rate [acty]    
High [qlco]    
patient [podg]    
Age [orga]    
/40 [tmco]    
year [tmco]    
/40 [tmco]    
year [tmco]    
baseline [bodm]    
Hepatitis B surface antigen level [lbpr]    
IU/mL [qnco]    
Optimal [qlco]    
Cutoff [ftcn]    
Value [qnco]    
post treatment [tmco]    
Hepatitis B Virus [virs]    
Relapse [phpr]    
post treatment [tmco]    
Hepatitis B Virus [virs]    
Relapse [phpr]    
Risk [qlco]    
Further [spco]    
Increase [qnco]    
Presence [topp]    
Risk factor [qnco]    
year [tmco]    
baseline [bodm]    
IU/mL [qnco]    
Prolonged [tmco]    
Consolidation Therapy [topp]    
period [tmco]    
month [tmco]    
Positive [qnco]    
Effect [qlco]    
sustain [ftcn]    
Viral [ftcn]    
suppress [patf]    
Significance [qnco]    
*Difference [qnco]    
post treatment [tmco]    
Hepatitis B Virus [virs]    
Relapse [phpr]    
Rate [acty]    
patient [podg]    
Induce [ftcn]    
Hepatitis B e antigen [imft]    
Loss [qnco]    
Off Treatment [ftcn]    
Follow-up [fndg]    
31 [inpr]    
Combination [qlco]    
Age [orga]    
/40 [tmco]    
year [tmco]    
baseline [bodm]    
Hepatitis B surface antigen level [lbpr]    
IU/mL [qnco]    
use [ftcn]    
Marker [clna]    
post treatment [tmco]    
Hepatitis B Virus [virs]    
Relapse [phpr]    
patient [podg]    
Induce [ftcn]    
Hepatitis B e antigen [imft]    
Loss [qnco]    
